243 related articles for article (PubMed ID: 22958439)
1. ABO blood group is a predictor of survival in patients undergoing surgery for renal cell carcinoma.
Kaffenberger SD; Morgan TM; Stratton KL; Boachie AM; Barocas DA; Chang SS; Cookson MS; Herrell SD; Smith JA; Clark PE
BJU Int; 2012 Dec; 110(11 Pt B):E641-6. PubMed ID: 22958439
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of ABO blood group in patients with renal cell carcinoma: single-institution results from a large cohort.
Lee C; You D; Sohn M; Jeong IG; Song C; Kwon T; Hong B; Hong JH; Ahn H; Kim CS
J Cancer Res Clin Oncol; 2015 Aug; 141(8):1441-7. PubMed ID: 25687379
[TBL] [Abstract][Full Text] [Related]
3. Statin use is associated with improved survival in patients undergoing surgery for renal cell carcinoma.
Kaffenberger SD; Lin-Tsai O; Stratton KL; Morgan TM; Barocas DA; Chang SS; Cookson MS; Herrell SD; Smith JA; Clark PE
Urol Oncol; 2015 Jan; 33(1):21.e11-21.e17. PubMed ID: 25456998
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Significance of Blood Type A in Patients with Renal Cell Carcinoma.
Ko K; Park YH; Jeong CW; Ku JH; Kim HH; Kwak C
Urol J; 2016 Aug; 13(4):2765-72. PubMed ID: 27576883
[TBL] [Abstract][Full Text] [Related]
5. Prognostic relevance of ABO blood group system in non-metastatic renal cell carcinoma: An analysis of two independent European cohorts with long-term follow-up.
Barth DA; Sareban N; Lindner AK; Daller LAJ; Matzhold EM; Hutterer G; Smolle M; Mischinger J; Riedl JM; Seles M; Mannweiler S; Bauernhofer T; Pummer K; Pichler R; Zigeuner R; Schlenke P; Pichler M
Urol Oncol; 2021 Oct; 39(10):736.e9-736.e16. PubMed ID: 34247906
[TBL] [Abstract][Full Text] [Related]
6. Preoperative nutritional status is an important predictor of survival in patients undergoing surgery for renal cell carcinoma.
Morgan TM; Tang D; Stratton KL; Barocas DA; Anderson CB; Gregg JR; Chang SS; Cookson MS; Herrell SD; Smith JA; Clark PE
Eur Urol; 2011 Jun; 59(6):923-8. PubMed ID: 21295907
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of ABO blood group as a prognostic marker in renal cell carcinoma (RCC).
de Martino M; Waldert M; Haitel A; Schatzl G; Shariat SF; Klatte T
BJU Int; 2014 May; 113(5b):E62-6. PubMed ID: 24053513
[TBL] [Abstract][Full Text] [Related]
8. Perioperative Allogenic Blood Transfusion in Renal Cell Carcinoma: Risk Factors and Effect on Long-term Outcomes.
Soria F; de Martino M; Leitner CV; Moschini M; Shariat SF; Klatte T
Clin Genitourin Cancer; 2017 Jun; 15(3):e421-e427. PubMed ID: 28089722
[TBL] [Abstract][Full Text] [Related]
9. Gender differences in clinicopathological features and survival in surgically treated patients with renal cell carcinoma: an analysis of the multicenter CORONA database.
May M; Aziz A; Zigeuner R; Chromecki T; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Tubaro A; Coman I; Truss M; Dalpiaz O; Hoschke B; Gilfrich C; Feciche B; Stoltze A; Fenske F; Fritsche HM; Figenshau RS; Madison K; Sánchez-Chapado M; Martin Mdel C; Salzano L; Lotrecchiano G; Joniau S; Waidelich R; Stief C; Brookman-May S;
World J Urol; 2013 Oct; 31(5):1073-80. PubMed ID: 23568445
[TBL] [Abstract][Full Text] [Related]
10. Preoperative metastatic status, level of thrombus and body mass index predict overall survival in patients undergoing nephrectomy and inferior vena cava thrombectomy.
Spiess PE; Kurian T; Lin HY; Rawal B; Kim T; Sexton WJ; Pow-Sang JM
BJU Int; 2012 Dec; 110(11 Pt B):E470-4. PubMed ID: 22519938
[TBL] [Abstract][Full Text] [Related]
11. Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma.
Jorns J; Thiel DD; Lohse CM; Williams A; Arnold ML; Cheville JC; Leibovich BC; Parker AS
BJU Int; 2012 Oct; 110(7):956-60. PubMed ID: 22300498
[TBL] [Abstract][Full Text] [Related]
12. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
13. The impact of perioperative blood transfusion on survival after nephrectomy for non-metastatic renal cell carcinoma (RCC).
Linder BJ; Thompson RH; Leibovich BC; Cheville JC; Lohse CM; Gastineau DA; Boorjian SA
BJU Int; 2014 Sep; 114(3):368-74. PubMed ID: 24471825
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome of small, organ-confined renal cell carcinoma (RCC) is not always favourable.
Shindo T; Masumori N; Kobayashi K; Fukuta F; Hirobe M; Tonooka A; Hasegawa T; Kitamura H; Tsukamoto T
BJU Int; 2013 May; 111(6):941-5. PubMed ID: 23350965
[TBL] [Abstract][Full Text] [Related]
15. Role of preoperative platelet level in clinical and pathological outcomes after surgery for renal cortical malignancies.
Wosnitzer M; Polland A; Hai Q; Hruby G; McKiernan J
BJU Int; 2011 Jul; 108(1):73-9. PubMed ID: 21166746
[TBL] [Abstract][Full Text] [Related]
16. Paraneoplastic syndromes are associated with adverse prognosis among patients with renal cell carcinoma undergoing nephrectomy.
Moreira DM; Gershman B; Lohse CM; Boorjian SA; Cheville JC; Leibovich BC; Thompson RH
World J Urol; 2016 Oct; 34(10):1465-72. PubMed ID: 26914818
[TBL] [Abstract][Full Text] [Related]
17. Preoperative Measurement of the Modified Glasgow Prognostic Score Predicts Patient Survival in Non-Metastatic Renal Cell Carcinoma Prior to Nephrectomy.
Tsujino T; Komura K; Matsunaga T; Yoshikawa Y; Takai T; Uchimoto T; Saito K; Tanda N; Oide R; Minami K; Uehara H; Jeong SH; Taniguchi K; Hirano H; Nomi H; Ibuki N; Takahara K; Inamoto T; Azuma H
Ann Surg Oncol; 2017 Sep; 24(9):2787-2793. PubMed ID: 28643013
[TBL] [Abstract][Full Text] [Related]
18. Partial nephrectomy is not associated with an overall survival advantage over radical nephrectomy in elderly patients with stage Ib-II renal masses: An analysis of the national cancer data base.
Ristau BT; Handorf EA; Cahn DB; Kutikov A; Uzzo RG; Smaldone MC
Cancer; 2018 Oct; 124(19):3839-3848. PubMed ID: 30207380
[TBL] [Abstract][Full Text] [Related]
19. Prognostic role of tumour multifocality in renal cell carcinoma.
Siracusano S; Novara G; Antonelli A; Artibani W; Bertini R; Carini M; Carmignani G; Ciciliato S; Cunico SC; Lampropoulou N; Longo N; Martorana G; Minervini A; Mirone V; Simeone C; Simonato A; Valotto C; Zattoni F; Ficarra V;
BJU Int; 2012 Dec; 110(11 Pt B):E443-8. PubMed ID: 22502873
[TBL] [Abstract][Full Text] [Related]
20. Perioperative epidural analgesia is not associated with increased survival from renal cell cancer, but overall survival may be improved: a retrospective chart review.
Kovac E; Firoozbakhsh F; Zargar H; Fergany A; Elsharkawy H
Can J Anaesth; 2017 Jul; 64(7):754-762. PubMed ID: 28417354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
